Published in Br J Pharmacol on March 03, 2010
The endocannabinoid system and cancer: therapeutic implication. Br J Pharmacol (2011) 1.46
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity. J Histochem Cytochem (2014) 1.09
Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget (2014) 1.05
Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Biol Psychiatry (2014) 0.98
Dynamic changes to the endocannabinoid system in models of chronic pain. Philos Trans R Soc Lond B Biol Sci (2012) 0.96
Skeletal lipidomics: regulation of bone metabolism by fatty acid amide family. Br J Pharmacol (2011) 0.88
Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia. Cell Mol Neurobiol (2014) 0.83
Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands. Mol Pain (2011) 0.83
Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. Psychopharmacology (Berl) (2011) 0.83
Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity. Br J Pharmacol (2015) 0.82
CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain. Behav Pharmacol (2011) 0.82
The neurobiology of cancer pain. Neuroscientist (2014) 0.81
Contributions of academic laboratories to the discovery and development of chemical biology tools. J Med Chem (2013) 0.81
Downregulation of PI3Kcb utilizing adenovirus-mediated transfer of siRNA attenuates bone cancer pain. Int J Clin Exp Pathol (2014) 0.77
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis. J Biol Chem (2015) 0.77
CCL2 released at tumoral level contributes to the hyperalgesia evoked by intratibial inoculation of NCTC 2472 but not B16-F10 cells in mice. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.76
The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief. ISRN Anesthesiol (2011) 0.76
The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. PLoS One (2011) 0.76
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent. Breast Cancer (Dove Med Press) (2016) 0.75
Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain. Mol Pain (2017) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol (2008) 13.18
Intrathecal morphine in mice: a new technique. Eur J Pharmacol (1980) 5.99
Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science (2005) 5.12
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res (2006) 2.62
CB2 cannabinoid receptor-mediated peripheral antinociception. Pain (2001) 2.38
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A (2005) 2.36
HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci U S A (1999) 2.32
Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci (2006) 2.32
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A (2003) 2.29
Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci (2003) 2.25
Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci (1999) 2.19
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol (2007) 2.01
Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature (1996) 1.94
Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci (2006) 1.85
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur J Neurosci (2006) 1.80
ASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammation. Pain (2006) 1.79
Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience (2005) 1.76
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest (2003) 1.61
Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology (2003) 1.60
The mammalian exercise pressor reflex in health and disease. Exp Physiol (2005) 1.52
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther (2008) 1.45
Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience (2003) 1.42
Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci (2005) 1.41
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci (2004) 1.40
Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology (2008) 1.39
Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience (1999) 1.37
Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology (2001) 1.35
Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. J Neurophysiol (2004) 1.33
Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Br J Pharmacol (2006) 1.32
Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience (2005) 1.30
Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology (2007) 1.30
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain (2003) 1.25
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models. Br J Pharmacol (2007) 1.20
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience (2003) 1.20
Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system. Int J Cancer (2003) 1.15
Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood (1998) 1.13
A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. J Neurosci (2008) 1.13
Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats. J Pharmacol Exp Ther (2008) 1.10
Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons. Pain (2008) 1.10
Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain. Eur J Pharmacol (2008) 1.07
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia. Eur J Pharmacol (2006) 1.06
Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain (2009) 1.05
Translational medicine: cancer pain mechanisms and management. Br J Anaesth (2008) 1.05
Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats. Eur J Neurosci (2008) 1.04
Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. Neuropharmacology (2003) 1.04
Targeting cannabinoid agonists for inflammatory and neuropathic pain. Expert Opin Investig Drugs (2007) 0.98
Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. J Neurosci Methods (2002) 0.97
Peripheral cannabinoids attenuate carcinoma-induced nociception in mice. Neurosci Lett (2008) 0.96
Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain. Mol Neurobiol (2007) 0.96
Cannabinoid type 2 receptor as a target for chronic - pain. Mini Rev Med Chem (2009) 0.93
Antihyperalgesic effects induced by the IL-1 receptor antagonist anakinra and increased IL-1beta levels in inflamed and osteosarcoma-bearing mice. Life Sci (2007) 0.93
Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett (2005) 0.93
The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms. Brain Res (2008) 0.92
Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain. Brain Res (2003) 0.89
Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.87
Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.84
Endogenous beta-endorphin induces thermal analgesia at the initial stages of a murine osteosarcoma. Peptides (2006) 0.79
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor. Eur J Pharmacol (2007) 0.79
Local loperamide inhibits thermal hyperalgesia but not mechanical allodynia induced by intratibial inoculation of melanoma cells in mice. Cell Mol Neurobiol (2008) 0.78
Cannabinoids in cancer pain management. J Pain Palliat Care Pharmacother (2006) 0.76
A protein with several possible membrane-spanning domains encoded by the Drosophila segment polarity gene patched. Nature (1989) 1.77
Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood (2001) 1.76
Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med (2006) 1.22
Regulation of wingless transcription in the Drosophila embryo. Development (1993) 1.14
Glia maintain follower neuron survival during Drosophila CNS development. Development (2000) 1.06
Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol (2000) 1.03
Gliatrophic and gliatropic roles of PVF/PVR signaling during axon guidance. Glia (2008) 1.01
HOXB homeobox gene expression in cervical carcinoma. Int J Gynecol Cancer (2006) 1.00
Prospective evaluation of esophageal motor dysfunction in Down's syndrome. Am J Gastroenterol (2001) 1.00
Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. Int Immunol (1999) 0.97
Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse. Diabetologia (2010) 0.97
Depolarization-dependent effect of flavonoids in rat uterine smooth muscle contraction elicited by CaCl2. Gen Pharmacol (1997) 0.96
Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis. Vaccine (2004) 0.96
Non-immunological hydrops fetalis and intrapericardial teratoma: case report and review. Prenat Diagn (1995) 0.95
Lichtenstein inguinal hernioplasty: sutures versus glue. Hernia (2005) 0.94
Prenatal diagnosis of idiopathic neonatal hemochromatosis with MRI. Abdom Imaging (1994) 0.91
Characterization of TGF-beta 1-binding proteins in human bone marrow stromal cells. Br J Haematol (1996) 0.90
Effects of oxytocin on the isolated vas deferens of the rat. Br J Pharmacol (1980) 0.90
Roundabout signalling, cell contact and trophic support confine longitudinal glia and axons in the Drosophila CNS. Development (2001) 0.89
Spontaneous aortocaval fistula: CT findings with pathologic correlation. Abdom Imaging (1995) 0.89
Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab. Pharmacoepidemiol Drug Saf (2008) 0.88
Safety profile of proton pump inhibitors according to the spontaneous reports of suspected adverse reactions. Int J Clin Pharmacol Ther (2006) 0.88
Mechanisms involved in the relaxant effect of estrogens on rat aorta strips. Life Sci (1996) 0.87
Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice. Brain Res (1993) 0.87
Pharmacological dissociation of UTP- and ATP-elicited contractions and relaxations in isolated rat aorta. Eur J Pharmacol (1995) 0.87
A precursor of the nitric oxide donor SIN-1 modulates the stress protein heme oxygenase-1 in rat liver. Biochem Biophys Res Commun (1996) 0.86
In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding. Brain Res (1992) 0.86
Sex-related differences in the effects of morphine and stress on visceral pain. Neuropharmacology (1989) 0.85
Meningitis due to Streptococcus suis with no contact with pigs or porcine products. J Infect (2007) 0.85
Differential use of very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells to adhere to transforming growth factor-beta1-treated bone marrow stroma. J Biol Chem (1998) 0.85
Automatic cell counting in vivo in the larval nervous system of Drosophila. J Microsc (2012) 0.85
MR imaging of multifocal spondylodiskitis as the initial manifestations of SAPHO syndrome. AJR Am J Roentgenol (1998) 0.84
Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study. Eur J Radiol (2010) 0.84
A PvuII polymorphism in the 5' flanking region of the apolipoprotein AIV gene: its use to study genetic variation determining serum lipid and apolipoprotein concentration. Hum Genet (1988) 0.84
[Store-and-forward teledermatology: assessment of validity in a series of 2000 observations]. Actas Dermosifiliogr (2011) 0.84
Fibrin glue reduces the severity of intra-abdominal adhesions in a rat model. Am J Surg (1999) 0.83
Biodegradation of phenol in synthetic and industrial wastewater by Rhodococcus erythropolis UPV-1 immobilized in an air-stirred reactor with clarifier. Appl Microbiol Biotechnol (2002) 0.83
Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression). Pharmacogenomics J (2006) 0.83
Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex. Br J Dermatol (2011) 0.82
The neonatal treatment of rats with monosodium glutamate induces morphological changes in the subfornical organ. Anat Histol Embryol (2004) 0.82
Culture of porcine hepatocytes: the dogma of exogenous matrix revisited. Artif Organs (2001) 0.82
Involvement of cAMP and beta-adrenoceptors in the relaxing effect elicited by flavonoids on rat uterine smooth muscle. J Auton Pharmacol (1999) 0.81
[Primary pyomyositis of the psoas muscles in a temperate climate. Review of two cases in children followed up over the long term]. An Sist Sanit Navar (2007) 0.80
Very low prevalence and no clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: the BHOI study. HIV Clin Trials (2008) 0.80
Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy. Pharmacol Biochem Behav (1991) 0.79
Influence of hormonal status in relaxant effect of diethylstilbestrol and nifedipine on isolated rat uterus contraction. Gen Pharmacol (1995) 0.79
Dorsal dislocation of the first metatarsophalangeal joint. Int Orthop (1994) 0.79
Extracellular and intracellular effects of polyamines on smooth muscle contractions. Life Sci (1995) 0.79
Use of an autologous bioengineered composite skin in extensive burns: Clinical and functional outcomes. A multicentric study. Burns (2011) 0.79
Intrathecal N-methyl-D-aspartate (NMDA) induces paradoxical analgesia in the tail-flick test in rats. Pharmacol Biochem Behav (2000) 0.78
Positive inotropism induced by androgens in isolated left atrium of rat: evidence for a cAMP-dependent transcriptional mechanism. Life Sci (1999) 0.78
Mechanisms involved in kaempferol-induced relaxation in rat uterine smooth muscle. Life Sci (2000) 0.78
Involvement of K(ATP) channels in diethylstilbestrol-induced relaxation in rat aorta. Eur J Pharmacol (2001) 0.78
Spinal calmodulin inhibitors reduce N-methyl-D-aspartate- and septide-induced nociceptive behavior. Eur J Pharmacol (1997) 0.78
The action of antibiotics on carotenoid production by strains of Sarcina lutea. Z Allg Mikrobiol (1970) 0.78
Effects of vanadate in testicular capsule of the rat. Gen Pharmacol (1991) 0.77
Estrogen and antiestrogen non-genomic effect in rat uterus contraction in calcium-free solution. Gen Pharmacol (1993) 0.77
Increases in ornithine decarboxylase activity in the positive inotropism induced by androgens in isolated left atrium of the rat. Eur J Pharmacol (2001) 0.77
Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of delta-opioid receptors. Peptides (1991) 0.77
Gender and test dependence of a type of kappa mediated stress induced analgesia in mice. Gen Pharmacol (1994) 0.77
Effects of diethylstilbestrol on mouse hippocampal evoked potentials in vitro. Cell Mol Neurobiol (1999) 0.77
Progesterone and pregnanolone derivatives relaxing effect on smooth muscle. Gen Pharmacol (1994) 0.77
Effects of the calcium release inhibitor dantrolene and the Ca2+-ATPase inhibitor thapsigargin on spinal nociception in rats. Pharmacology (2001) 0.77
Effect of spermine and alpha-difluoromethylornithine on KCl- and CaCl2-induced contraction in rat uterine smooth muscle. J Auton Pharmacol (1998) 0.77
Calcium and depolarization-dependent effect of pregnenolone derivatives on uterine smooth muscle. Gen Pharmacol (1996) 0.77
A catalogue of molecular, physiological and symbiotic properties of soybean-nodulating rhizobial strains from different soybean cropping areas of China. Syst Appl Microbiol (2003) 0.77
Pharmacological evidence for the contribution of polyamines as mediators of the transcriptional component involved in smooth muscle relaxation elicited by forskolin. Life Sci (1997) 0.76
Transcriptional mechanisms involved in the relaxant effect of zeranol on isolated rat uterus. Gen Pharmacol (1997) 0.76
Partial contribution of polyamines to the relaxant effect of 17 alpha-estradiol in rat uterine smooth muscle. Gen Pharmacol (1998) 0.76
Different types of steroids inhibit [3H]diprenorphine binding in mouse brain membranes. Gen Pharmacol (1998) 0.76
Spinal effects of the calmodulin inhibitor calmidazolium on dorsal horn neurons in the rat. Acta Neurobiol Exp (Wars) (1999) 0.76
[Effect of calcium antagonists on the response of the rat vas deferens to noradrenaline and field stimulation]. Rev Esp Fisiol (1983) 0.76
Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer. Cancer Treat Rep (1986) 0.76
Calmodulin inhibitors induce spinal analgesia in rats. Brain Res (1996) 0.76
Nitric oxide and cyclic nucleotides participate in the relaxation of diclofenac on rat uterine smooth muscle. Gen Pharmacol (1998) 0.76
Non-genomic effects of catecholestrogens in the in vitro rat uterine contraction. Gen Pharmacol (1995) 0.76
Congenital hypofibrinogenemia and pregnancy, obstetric and hematological management. Gynecol Obstet Invest (1987) 0.76
Spasmolytic and calmodulin inhibitory effect of non-steroidal anti-inflammatory drugs in vitro. Life Sci (1995) 0.76
Effects of preanesthetic and anesthetic drugs on endothelium-dependent responses in the rat aorta. Gen Pharmacol (1995) 0.75
Novel approaches in the development of new analgesics. Neurophysiol Clin (1990) 0.75
Abdominal sparganosis in Ecuador: a case report. Am J Trop Med Hyg (1991) 0.75
Opioid footshock-induced analgesia in mice acutely falls by stress prolongation. Physiol Behav (1993) 0.75
Influence of some inhibitors of arachidonic acid metabolism on oxytocin contractions in the isolated testicular capsule of the rat. Eur J Pharmacol (1986) 0.75
[An awareness campaign on the diagnosis and prevention of colon and rectal cancer. Planning and evaluation of its results]. Acta Gastroenterol Latinoam (1987) 0.75
Habitual dislocation of the hip. Int Orthop (1988) 0.75